Lantronix to Report Fiscal 2019 Second Quarter Results on January 24, 2019
IRVINE, Calif., Jan. 14, 2019 (GLOBE NEWSWIRE) — Lantronix, Inc. (NASDAQ: LTRX), a global provider of secure data access and […]
LiveArea and BigCommerce Join Forces to Provide Comprehensive Professional Services for Online Commerce
Services will help fast-growing B2C and B2B businesses scale and sell more online ALLEN, Texas, Jan. 14, 2019 (GLOBE NEWSWIRE) […]
Phunware Announces the PhunCoin Launch Alliance
AUSTIN, Texas, Jan. 14, 2019 (GLOBE NEWSWIRE) — Today Phunware (NASDAQ: PHUN), a leading enterprise cloud platform for mobile which […]
Shaw Declares Monthly Dividends
CALGARY, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) announced today that its Board of Directors has […]
Shaw Declares Dividend Payable on Preferred Shares
CALGARY, Alberta, Jan. 14, 2019 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) announced today that its Board of Directors has […]
B. Riley FBR Repositions Research Platform to Focus on Small and Mid-Cap Opportunities
LOS ANGELES, Jan. 14, 2019 (GLOBE NEWSWIRE) — B. Riley FBR, Inc., a leading full service investment bank and wholly-owned […]
EDAP TMS SA : EDAP Announces Sales of Two Additional Focal One® Devices in Brazil
Hospital 9 de Julho and Hospital Moriah join growing roster of highly-regarded hospitals in Brazil offering Focal One LYON, France, […]
Inspire Medical Systems, Inc. Announces First BCBS Coverage Policy following Evidence Street’s Positive Therapy Indication Summary
MINNEAPOLIS, Jan. 14, 2019 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on […]
Rexahn Announces Presentation of RX-3117 Data at the 2019 ASCO Gastrointestinal Cancers Symposium
ROCKVILLE, Md., Jan. 14, 2019 (GLOBE NEWSWIRE) — Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing […]
InspireMD Announces the Distribution of CGuard™ Embolic Prevention System in South Africa
Growing awareness of CGuard™ EPS among treating physicians, and resulting demand, were key factors driving entry into the South African […]
